Nano Magic CEO talks mission for nanotechnology innovation

Video
Conference|Vision Expo East

Nano Magic's Tom Berman discusses the company's origins and mission in creating nanotech-powered solutions.

Following Vision Expo East, Optometry Times®' Alex Delaney-Gesing catchups up with Tom Berman, president/CEO of Nano Magic, as he discusses the company's origins and mission in creating nanotech-powered solutions.

See more Vision Expo East coverage

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Naureen Haroon, OD, MPH, FAAO, founder of the newly formed WHSIG, said the group's primary aim is to educate the optometric community about why certain eye conditions disproportionately affect women.
Jade Coats, OD, FAAO, gives her insight on what makes EyeCon valuable for eye care providers.
Allen, OD, FAAO, Dipl ABO, plans to talk all things ocular surface for optometrists and ophthalmologists alike.
Related Content
Trophies on black backdrop Image credit: AdobeStock/ATKWORK888

American Academy of Optometry 2025 award recipients in the books

Jordana Joy, Associate Editor
September 12th 2025
Article
VEW 2022: Guess again, your child is NOT too young for contact lenses

VEW 2022: Guess again, your child is NOT too young for contact lenses

Vittorio Mena, OD, MS,;Kassi Filkins, Editor
September 12th 2025
Podcast
Children on bikes wearing glasses. Image credit: SightGlass Vision

DOT lenses for slowing myopia progression worn by a total of 1 million children

Jordana Joy, Associate Editor
September 12th 2025
Article
VEW 2022: Concussion management with Dr. Mena

VEW 2022: Concussion management with Dr. Mena

Vittorio Mena, OD, MS,;Kassi Filkins, Editor
September 12th 2025
Podcast
Shovlin's detailed key points from his presentation, including the increased toxicity from targeted immunotherapies like CAR T-cell therapy and checkpoint inhibitors, which often require careful management to avoid vision-threatening complications.

AOA 2025: Ocular toxicities in cancer patients – A Q&A with Dr Joe Shovlin

Jordana Joy, Associate Editor
September 12th 2025
Article
Theis and Allen discussed how insufficient/short sleep duration is associated with an increased risk of early age-related macular degeneration and associations between sleep apnea and glaucoma, among other topics.

AOA 2025: Improving sleep hygiene for the sake of brain and ocular health

Jordana Joy, Associate Editor
September 12th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.